Brandes, A. A., Gil‐Gil, M., Saran, F., Carpentier, A. F., Nowak, A. K., Mason, W., . . . Pichler, J. (2018). A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma. Oncologist.
Citação norma ChicagoBrandes, Alba A., et al. "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma." Oncologist 2018.
ציטוט MLABrandes, Alba A., et al. "A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma." Oncologist 2018.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.